ACLX
Price
$72.62
Change
+$0.46 (+0.64%)
Updated
Sep 5 closing price
Capitalization
4.03B
72 days until earnings call
CLSD
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
27.16M
73 days until earnings call
Interact to see
Advertisement

ACLX vs CLSD

Header iconACLX vs CLSD Comparison
Open Charts ACLX vs CLSDBanner chart's image
Arcellx
Price$72.62
Change+$0.46 (+0.64%)
Volume$364.16K
Capitalization4.03B
Clearside Biomedical
Price$0.35
Change-$0.00 (-0.00%)
Volume$453.33K
Capitalization27.16M
ACLX vs CLSD Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. CLSD commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and CLSD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ACLX: $72.62 vs. CLSD: $0.35)
Brand notoriety: ACLX and CLSD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 75% vs. CLSD: 8%
Market capitalization -- ACLX: $4.03B vs. CLSD: $27.16M
ACLX [@Biotechnology] is valued at $4.03B. CLSD’s [@Biotechnology] market capitalization is $27.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCLSD’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CLSD’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 7 TA indicator(s) are bullish while CLSD’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 7 bullish, 2 bearish.
  • CLSD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than CLSD.

Price Growth

ACLX (@Biotechnology) experienced а +4.65% price change this week, while CLSD (@Biotechnology) price change was -5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

CLSD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.03B) has a higher market cap than CLSD($27.2M). ACLX YTD gains are higher at: -5.307 vs. CLSD (-63.579). CLSD has higher annual earnings (EBITDA): -16.2M vs. ACLX (-179.78M). ACLX has more cash in the bank: 453M vs. CLSD (9.38M). CLSD has less debt than ACLX: CLSD (533K) vs ACLX (52.5M). ACLX has higher revenues than CLSD: ACLX (57M) vs CLSD (4.17M).
ACLXCLSDACLX / CLSD
Capitalization4.03B27.2M14,805%
EBITDA-179.78M-16.2M1,109%
Gain YTD-5.307-63.5798%
P/E RatioN/AN/A-
Revenue57M4.17M1,368%
Total Cash453M9.38M4,831%
Total Debt52.5M533K9,850%
FUNDAMENTALS RATINGS
CLSD: Fundamental Ratings
CLSD
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXCLSD
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSYS9.300.12
+1.31%
Nortech Systems
GHC1131.443.22
+0.29%
Graham Holdings Company
ZTS153.320.12
+0.08%
ZOETIS
HSII50.37-0.12
-0.24%
Heidrick & Struggles International
PVBC12.85-0.12
-0.93%
Provident Bancorp

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RNA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.64%
RNA - ACLX
55%
Loosely correlated
+3.90%
CGON - ACLX
55%
Loosely correlated
+6.88%
ROIV - ACLX
54%
Loosely correlated
+2.78%
CRNX - ACLX
52%
Loosely correlated
+3.97%
SYRE - ACLX
52%
Loosely correlated
+0.06%
More

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
-1.23%
ABVX - CLSD
51%
Loosely correlated
+2.90%
ANEB - CLSD
31%
Poorly correlated
-0.42%
BOLT - CLSD
31%
Poorly correlated
+7.23%
IMNN - CLSD
30%
Poorly correlated
+0.61%
ACLX - CLSD
28%
Poorly correlated
+0.64%
More